Halozyme Therapeutics | HALO - Выручка от реализации





Продажи Изменить Дата
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amarin USD 49.22M 451K 2025-12
Amgen USD 10.1B 1.48B 2026-06
Baxter International USD 2.96B 260M 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cytokinetics USD 19.35M 1.59M 2026-03
DBV Technologies USD 645K 2.13M 2025-12
Eli Lilly USD 22.97B 3.17B 2026-06
Halozyme Therapeutics USD 377M 74.76M 2026-03
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
MannKind USD 90.2M 21.76M 2026-03
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Pfizer USD 15.03B 530M 2026-06
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
United Therapeutics USD 783.3M 1.8M 2026-06
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12